News and Press Releases
Phesi launches self-service Investigator Site Profiler solution to enhance precision of investigator site selection
Solution benefits clinical development and medical affairs groups – eliminating 20%-30% of investigator sites where there isn’t sufficient data to ensure performance 2 April 2025 -- Massachusetts, US -- Phesi,...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: April 2, 2025
Phesi announces AI-driven Trial Accelerator platform hits new milestone with data from 132 million patients
Latest version of Trial Accelerator™ incorporates new AI capabilities and product features to unlock a patient-centric approach to trial design and implementation 29 January 2025 -- Boston, US -- Phesi,...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 30, 2025
New Data Reveals Decentralized Clinical Trials Linked to Improved Diverse Participation Across Many Underrepresented Demographics
Asian participation increased by 6 percentage points; American Indian/Alaska Native participation quadrupled; Female participation rose from 49.0% to 55.7% 28 January 2025 -- California, US -- Medable Inc., a leading provider...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 28, 2025
Phesi launches Investigator Site Profile solution, enabling sponsors to eliminate non-active, non-enrolling trial sites
AI-powered analysis of 120m patient profiles and 600,000 global investigator records delivers deep visibility into investigator site expertise, experience and clinical relevance 26 September 2024 -- Massachusetts, US -- Phesi,...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 26, 2024
New Phesi proof of concept demonstrates potential of AI-powered digital twins to replace external control arms in clinical trials
Study published in Bone Marrow Transplantation uses real-world clinical data to create virtual digital twin cohorts instead of placebo and standard-of-care comparator arms 20 June 2024 -- Massachusetts, US --...
Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: June 20, 2024
Global oncology trial investigator sites increase by half in five years, finds new Phesi analysis
China flagged as significant contributor to growth, but poor investigator selection is causing trial failures 23 May 2024 -- Massachusetts, US -- Phesi, a leading clinical development analytics company, has...
Category: Biotechnology, Clinical Trials
Posted: May 22, 2024
Phesi launches predictive Patient Burden Score to improve trial efficiency, patient experience and investigator site performance
Latest real-world metric in Phesi’s AI-driven Trial Accelerator quantifies patient burden to unlock a patient-centric approach to trial design and implementation 7 May 2024 -- Boston, US -- Phesi, a...
Category: Clinical Trials
Posted: May 7, 2024
Education and tailored communications are required to bridge the ethnicity gap in clinical trial participation
6 in 10 (58%) adults in the UK reported that they would be willing to participate in a clinical trial. However, ethnic minority adults were significantly less likely to participate,...
Category: Clinical Trials
Posted: March 11, 2024
Phesi releases 2023 analysis of clinical development; breast cancer remains most studied disease area for third year
Annual analysis of data from 95 million patients shows signs of post-pandemic recovery for clinical development industry, but trial cancellation rates at phase 2 remain high 16 January 2024 --...
Category: Clinical Trials
Posted: January 16, 2024
Phesi launches Health Check and Trial Rescue Service to save at-risk trials and bring drugs to market faster
New free of charge service will offer insights in under ten days to sponsors conducting clinical trials in any indication, identifying potential “zombie trials” and providing actionable recommendations for failing...
Category: Pharmaceutical
Posted: October 12, 2023
Thermo Fisher Scientific and National Minority Quality Forum Collaborate to Make Clinical Research More Accessible to Historically Underserved Communities
7 September 2023 -- Massachusetts, US -- Thermo Fisher Scientific, the world leader in serving science, and the National Minority Quality Forum (NMQF), an independent not-for-profit research and education organisation,...
Category: Clinical Trials
Posted: September 7, 2023
Phesi and Krystelis collaborate to launch new Diversity, Equity and Inclusion Data Service for clinical development
New Diversity, Equity, and Inclusion (DEI) Data Service will harness data from 70 million patients to enable sponsors to create more diverse trials, reduce protocol amendments and meet new FDA...
Category: Clinical Trials
Posted: September 7, 2023
